More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/3,4-Dihydroxy-L-phenylalanine [59-92-7]
Chemical Structure
Chemical Structure
Chemical Structure

3,4-Dihydroxy-L-phenylalanine [59-92-7]

Research Use Only
CDX-D0465
Chemodex
CAS Number59-92-7
DownloadDatasheet
DownloadMSDS
Product group Chemicals
Estimated Purity>98%
Molecular Weight197.19
Price on request
Packing Size
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    Chemodex
  • Product Name
    3,4-Dihydroxy-L-phenylalanine [59-92-7]
  • Delivery Days Customer
    10
  • CAS Number
    59-92-7
  • Certification
    Research Use Only
  • Estimated Purity
    >98%
  • Hazard Information
    Warning
  • Molecular Formula
    C9H11NO4
  • Molecular Weight
    197.19
  • Scientific Description
    Chemical. CAS: 59-92-7. Formula: C9H11NO4. MW: 197.19. Synthetic. Metabolic precursor of the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), which are collectively known as catecholamines. This amino acid is produced from L-tyrosine by tyrosine hydroxylase and metabolized by catechol-O-methyl transferase (COMT). L-DOPA is capable of crossing the blood brain barrier where it is converted to dopamine. Formulations containing L-DOPA have been used to increase dopamine concentrations in the brain as a treatment for Parkinsons disease and stroke recovery. Mediates neurotrophic factor release by the brain and CNS. Used for the treatment of Parkinsons disease and dopamine-responsive dystonia. In addition it is used, as a cell adhesion molecule in serum-free cultures of anchorage-dependent mammalian cells, to prevent surfaces from fouling by bonding antifouling polymers to a susceptible substrate or to stain melanocytes. - Metabolic precursor of the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), which are collectively known as catecholamines. This amino acid is produced from L-tyrosine by tyrosine hydroxylase and metabolized by catechol-O-methyl transferase (COMT). L-DOPA is capable of crossing the blood brain barrier where it is converted to dopamine. Formulations containing L-DOPA have been used to increase dopamine concentrations in the brain as a treatment for Parkinsons disease and stroke recovery. Mediates neurotrophic factor release by the brain and CNS. Used for the treatment of Parkinsons disease and dopamine-responsive dystonia. In addition it is used, as a cell adhesion molecule in serum-free cultures of anchorage-dependent mammalian cells, to prevent surfaces from fouling by bonding antifouling polymers to a susceptible substrate or to stain melanocytes.
  • SMILES
    OC1=C(O)C=CC(C[C@H](N)C(O)=O)=C1
  • Storage Instruction
    RT
  • UNSPSC
    12352200